Guo L - Search Results

1

Clinicopathological characteristics and health care for Tibetan women with breast cancer: a cross-sectional survey.

Zhao Y, Luo H, Zhang X, Bianba T, Li L, Wang Q, Guo L, Wang D, Ze Y, Zheng S. Zhao Y, et al. Among authors: guo l. BMC Cancer. 2019 Apr 25;19(1):380. doi: 10.1186/s12885-019-5580-x. BMC Cancer. 2019. PMID: 31023263 Free PMC article.

2

[Comparison of histopathologic changes and expression of biomarkers in breast carcinoma before and after neoadjuvant chemotherapy].

Zheng S, Zhang BL, Xiao T, Zou SM, Xue LY, Luo W, Guo L, Liu XY, Lü N. Zheng S, et al. Among authors: guo l. Zhonghua Bing Li Xue Za Zhi. 2011 Jul;40(7):465-70. Zhonghua Bing Li Xue Za Zhi. 2011. PMID: 22088373 Chinese.

3

Evaluation of ER-α, ER-Β1 and ER-Β2 expression and correlation with clinicopathologic factors in invasive luminal subtype breast cancers.

Zhang H, Zhang Z, Xuan L, Zheng S, Guo L, Zhan Q, Qu X, Zhang B, Wang Y, Wang X, Song Y. Zhang H, et al. Among authors: guo l. Clin Transl Oncol. 2012 Mar;14(3):225-31. doi: 10.1007/s12094-012-0788-0. Clin Transl Oncol. 2012. PMID: 22374427

4

[Standard protocol of ALK fusion gene assessment by fluorescent in situ hybridization in non-small cell lung cancer].

Guo L, Zheng S, Xie YQ. Guo L, et al. Zhonghua Bing Li Xue Za Zhi. 2013 Aug;42(8):530-3. Zhonghua Bing Li Xue Za Zhi. 2013. PMID: 24246918 Chinese.

5

Prevalence and Clinicopathological Characteristics of HER2 and BRAF Mutation in Chinese Patients with Lung Adenocarcinoma.

Shan L, Qiu T, Ling Y, Guo L, Zheng B, Wang B, Li W, Li L, Ying J. Shan L, et al. Among authors: guo l. PLoS One. 2015 Jun 23;10(6):e0130447. doi: 10.1371/journal.pone.0130447. eCollection 2015. PLoS One. 2015. PMID: 26102513 Free PMC article.

6

Concurrence of EGFR amplification and sensitizing mutations indicate a better survival benefit from EGFR-TKI therapy in lung adenocarcinoma patients.

Shan L, Wang Z, Guo L, Sun H, Qiu T, Ling Y, Li W, Li L, Liu X, Zheng B, Lu N, Ying J. Shan L, et al. Among authors: guo l. Lung Cancer. 2015 Sep;89(3):337-42. doi: 10.1016/j.lungcan.2015.06.008. Epub 2015 Jun 19. Lung Cancer. 2015. PMID: 26141217

7

A suggestion for pathological grossing and reporting based on prognostic indicators of malignancies from a pooled analysis of renal epithelioid angiomyolipoma.

Zheng S, Bi XG, Song QK, Yuan Z, Guo L, Zhang H, Ma JH. Zheng S, et al. Among authors: guo l. Int Urol Nephrol. 2015 Oct;47(10):1643-51. doi: 10.1007/s11255-015-1079-9. Epub 2015 Aug 15. Int Urol Nephrol. 2015. PMID: 26271644 Review.

8

Immunohistochemistry of p53 and Ki-67 and p53 mutation analysis in renal epithelioid angiomyolipoma.

Li W, Guo L, Bi X, Ma J, Zheng S. Li W, et al. Among authors: guo l. Int J Clin Exp Pathol. 2015 Aug 1;8(8):9446-51. eCollection 2015. Int J Clin Exp Pathol. 2015. PMID: 26464702 Free PMC article.

9

Molecular pathological epidemiology of colorectal cancer in Chinese patients with KRAS and BRAF mutations.

Li W, Qiu T, Ling Y, Guo L, Li L, Ying J. Li W, et al. Among authors: guo l. Oncotarget. 2015 Nov 24;6(37):39607-13. doi: 10.18632/oncotarget.5551. Oncotarget. 2015. PMID: 26530529 Free PMC article.

10

Assessment of cytology based molecular analysis to guide targeted therapy in advanced non-small-cell lung cancer.

Li W, Zhang Z, Guo L, Qiu T, Ling Y, Cao J, Guo H, Zhao H, Li L, Ying J. Li W, et al. Among authors: guo h, guo l. Oncotarget. 2016 Feb 16;7(7):8332-40. doi: 10.18632/oncotarget.6671. Oncotarget. 2016. PMID: 26789109 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

21,787 results

Search Page

Filters